Your browser doesn't support javascript.
loading
Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis.
Van der Auwera, Gert; Davidsson, Leigh; Buffet, Pierre; Ruf, Marie-Thérèse; Gramiccia, Marina; Varani, Stefania; Chicharro, Carmen; Bart, Aldert; Harms, Gundel; Chiodini, Peter L; Brekke, Hanne; Robert-Gangneux, Florence; Cortes, Sofia; Verweij, Jaco J; Scarabello, Alessandra; Karlsson Söbirk, Sara; Guéry, Romain; van Henten, Saskia; Di Muccio, Trentina; Carra, Elena; van Thiel, Pieter; Vandeputte, Martin; Gaspari, Valeria; Blum, Johannes.
Afiliação
  • Van der Auwera G; Institute of Tropical Medicine, Antwerp, Belgium.
  • Davidsson L; The Public Health Agency of Sweden, Solna, Sweden.
  • Buffet P; Service des maladies infectieuses et tropicales, AP-HP, Hopital Necker, Paris, France.
  • Ruf MT; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Gramiccia M; University of Basel, Basel, Switzerland.
  • Varani S; Istituto Superiore di Sanità, Rome, Italy.
  • Chicharro C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Bart A; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
  • Harms G; Instituto de Salud Carlos III, Madrid, Spain.
  • Chiodini PL; Amsterdam University Medical Centre, Amsterdam, the Netherlands.
  • Brekke H; Institute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Berlin, Germany.
  • Robert-Gangneux F; Hospital for Tropical Diseases, London, United Kingdom.
  • Cortes S; Oslo University Hospital, Oslo, Norway.
  • Verweij JJ; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset - UMR_S 1085, Rennes, France.
  • Scarabello A; Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisbon, Portugal.
  • Karlsson Söbirk S; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
  • Guéry R; National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy.
  • van Henten S; Division of Infection Medicine, Lund University, Lund, Sweden.
  • Di Muccio T; Hôpital privé du Confluent, Nantes, France.
  • Carra E; Institute of Tropical Medicine, Antwerp, Belgium.
  • van Thiel P; Istituto Superiore di Sanità, Rome, Italy.
  • Vandeputte M; Istituto Zooprofilattico Sperimentale della Lombardia e dell' Emilia-Romagna 'Bruno Ubertini', Brescia, Italy.
  • Gaspari V; Amsterdam University Medical Centre, Amsterdam, the Netherlands.
  • Blum J; Institute of Tropical Medicine, Antwerp, Belgium.
Euro Surveill ; 27(4)2022 Jan.
Article em En | MEDLINE | ID: mdl-35086613
ABSTRACT
BackgroundSurveillance of human leishmaniasis in Europe is mostly limited to country-specific information from autochthonous infections in the southern part. As at the end of 2021, no integrated analysis has been performed for cases seen across centres in different European countries.AimTo provide a broad perspective on autochthonous and imported leishmaniasis cases in endemic and non-endemic countries in Europe.MethodsWe retrospectively collected records from cutaneous, mucosal and visceral leishmaniasis cases diagnosed in 15 centres between 2014 and 2019. Centres were located in 11 countries Belgium, France, Germany, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom. Data on country of infection, reason for travelling, infecting species, age and sex were analysed.ResultsWe obtained diagnostic files from 1,142 cases, of which 76%, 21% and 3% had cutaneous, visceral, and mucosal disease, respectively. Of these, 68% were men, and 32% women, with the median age of 37 years (range 0-90) at diagnosis. Visceral leishmaniasis was mainly acquired in Europe (88%; 167/190), while cutaneous leishmaniasis was primarily imported from outside Europe (77%; 575/749). Sixty-two percent of cutaneous leishmaniasis cases from outside Europe were from the Old World, and 38% from the New World. Geographic species distribution largely confirmed known epidemiology, with notable exceptions.ConclusionsOur study confirms previous reports regarding geographic origin, species, and traveller subgroups importing leishmaniasis into Europe. We demonstrate the importance of pooling species typing data from many centres, even from areas where the aetiology is presumably known, to monitor changing epidemiology.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmaniose / Leishmaniose Cutânea / Leishmaniose Visceral Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmaniose / Leishmaniose Cutânea / Leishmaniose Visceral Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica